109 related articles for article (PubMed ID: 7273762)
1. Cyclic variation of proteinase inhibitors in human uterine fluid and influence of an IUD.
Casslén B; Ohlsson K
Contraception; 1981 Apr; 23(4):425-34. PubMed ID: 7273762
[TBL] [Abstract][Full Text] [Related]
2. Effect of the intrauterine contraceptive device on protein components of human uterine fluid.
Tauber PF; Cramer GM; Zaneveld LJ
Contraception; 1993 Nov; 48(5):494-512. PubMed ID: 8275697
[TBL] [Abstract][Full Text] [Related]
3. Cyclic variation of plasminogen activation in human uterine fluid and the influence of an intrauterine device.
Casslén B; Ohlsson K
Acta Obstet Gynecol Scand; 1981; 60(2):97-101. PubMed ID: 6454324
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolytic activity of uterine fluid in IUD-users.
Casslén B; Astedt B
Acta Obstet Gynecol Scand; 1981; 60(1):59-62. PubMed ID: 7211237
[TBL] [Abstract][Full Text] [Related]
5. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
[TBL] [Abstract][Full Text] [Related]
6. Cytologic atypias in the uterine fluid of intrauterine contraceptive device users.
Kobayashi TK; Casslén B; Stormby N
Acta Cytol; 1983; 27(2):138-41. PubMed ID: 6573085
[TBL] [Abstract][Full Text] [Related]
7. Alpha 1-antitrypsin--complexation and inactivation in the uterine fluid of IUD-users.
Casslén B; Ohlsson K
Acta Obstet Gynecol Scand; 1981; 60(2):103-7. PubMed ID: 7018161
[TBL] [Abstract][Full Text] [Related]
8. Effect of IUD on urokinase-like immunoreactivity and plasminogen activators in human uterine fluid.
Casslén B; Thorell J; Astedt B
Contraception; 1981 Apr; 23(4):435-45. PubMed ID: 7023822
[TBL] [Abstract][Full Text] [Related]
9. Proteinases and proteinase inhibitors in uterine fluid with special reference to IUD-users.
Casslén B
Acta Obstet Gynecol Scand Suppl; 1981; 98():1-38. PubMed ID: 7018160
[No Abstract] [Full Text] [Related]
10. Human uterine fluid, examined in undiluted samples for osmolarity and the concentrations of inorganic ions, albumin, glucose, and urea.
Casslén B; Nilsson B
Am J Obstet Gynecol; 1984 Dec; 150(7):877-81. PubMed ID: 6507514
[TBL] [Abstract][Full Text] [Related]
11. The cellular composition of uterine fluid in IUD users - a quantitative study.
Casslén B; Kobayashi TK; Stormby N
Contraception; 1981 Dec; 24(6):685-93. PubMed ID: 7326938
[TBL] [Abstract][Full Text] [Related]
12. Sialic acid and sialidase activity in human endometrial tissue, uterine fluid and plasma under different conditions of uterine dysfunction.
Ganguly S; Sarkar D; Ghosh JJ
Acta Endocrinol (Copenh); 1976 Mar; 81(3):574-9. PubMed ID: 946346
[TBL] [Abstract][Full Text] [Related]
13. [Endometrial cytology and copper containing intrauterine devices].
Herting W; Tauber PF
Fortschr Med; 1978 Feb; 96(7):311-4. PubMed ID: 304829
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of intrauterine devices: biochemical changes.
Johannisson E
Contraception; 1987 Jul; 36(1):11-22. PubMed ID: 3311620
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic activity of human uterine fluid.
Casslén B; Astedt B
Acta Obstet Gynecol Scand; 1981; 60(1):55-8. PubMed ID: 7211236
[TBL] [Abstract][Full Text] [Related]
16. Uterine fluid volume. Cyclic variations and possible extrauterine contributions.
Casslén B
J Reprod Med; 1986 Jun; 31(6):506-10. PubMed ID: 3735263
[TBL] [Abstract][Full Text] [Related]
17. Effect of an intrauterine contraceptive device on urea content of uterine fluid.
Kar AB; Engineer AD; Dasgupta PR; Srivastava AK
Am J Obstet Gynecol; 1969 Jun; 104(4):607-8. PubMed ID: 5786713
[TBL] [Abstract][Full Text] [Related]
18. Intrauterine contraception with the copper-T device. 4. Influence on protein and copper concentrations and enzyme activities in uterine washings.
Hagenfeldt K
Contraception; 1972 Sep; 6(3):219-30. PubMed ID: 4568282
[TBL] [Abstract][Full Text] [Related]
19. Characterization of copper in uterine fluids of patients who use the copper T-380A intrauterine device.
Arancibia V; Peña C; Allen HE; Lagos G
Clin Chim Acta; 2003 Jun; 332(1-2):69-78. PubMed ID: 12763282
[TBL] [Abstract][Full Text] [Related]
20. Localization and quantitation of a low molecular weight proteinase inhibitor, antileukoprotease, in the human uterus.
Casslén B; Rosengren M; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1981 Jul; 362(7):953-61. PubMed ID: 6792034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
